Dr Daphne Jo Valmonte-Panganiban, Radiation Oncology Specialist

11/04/2026

11/04/2026

Stage IV cancer — but not all the same.

Oligometastatic disease (≤5 lesions) represents a unique window—not a lost case, but an opportunity.

In selected patients, treating each site can:
• prolong the benefit of systemic therapy
• enhance immunomodulatory effects and synergy with immunotherapy
• improve progression-free and even overall survival (histology-dependent)

Stereotactic Body Radiotherapy (SBRT) via CyberKnife delivers high-dose, submillimeter precision—maximizing tumor control while protecting nearby critical organs.

Because in radiation oncology, great outcomes start with great planning.

27/03/2026

A new milestone shines brightly—Asian Hospital celebrates its first 𝟏𝟎𝟎 𝐂𝐲𝐛𝐞𝐫𝐊𝐧𝐢𝐟𝐞 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬, marking another breakthrough in cancer care.

Behind every number is a story of courage, healing, and compassion. This achievement is not just about innovation—it’s about people. Patients who fought bravely, and the dedicated doctors and staff who stood by them every step of the way.

This meaningful event was graced by distinguished guests from the Department of Trade and Industry, the Executive Director of the Board of Investments, the Honorable Mayor of Muntinlupa, and our Media Partners.

This is a testament that hope isn’t something hard to reach—because every Filipino deserves nothing but the best care, the brightest chance, and a future worth fighting for.

If you or your loved one is seeking advanced cancer care, let hope lead the way.

Learn more about Cyberknife: https://www.asianhospital.com/news/a-new-hope-for-cancer-introducing-the-first-ever-cyberknife-in-the-philippines/

20/03/2026

20/03/2026

A meaningful day at the recent Philippine Radiation Oncology Society Annual Convention—surrounded by mentors, peers, and friends all working toward one goal: better outcomes for our patients.

Always grateful to learn, to share, and to grow alongside this community. 🤍

15/03/2026

Debunking a radiotherapy myth: Hindi nakakahawa ng radiation ang mga pasyenteng nageexternal beam radiotherapy para sa cancer. HIndi sila kailangan bumukod sa kahit na sino.

26/02/2026

Most cancers do not have symptoms during their early stages.

Eliminate worries by undergoing cancer screening. Available packages at MakatiMed:

• Female Cancer Screening – PhP 16,500
• Male Cancer Screening – PhP 16,000
• Liver Cancer Screening – PhP 21,000

MakatiMed Cancer Institute
📍 1st Floor, Tower 1
📞 (632) 8888 8999 locals 7102, 7103 & 7113

14/02/2026

In this infographic you have a structured synthesis of current screening recommendations based on official guidance from:

➡️ United States: U.S. Preventive Services Task Force (USPSTF), American Cancer Society (ACS).

➡️ Europe: European Commission (EU Council Recommendations 2022 update), and position statements from European Society for Medical Oncology (ESMO).

➡️ Only population-based screening with sufficient evidence is included.

Tony Leachon

13/02/2026

The reason why I do what I do.

06/02/2026

On this , ESTRO and ASTRO stand together, . We are committed to ensuring that every patient has access to modern radiotherapy that is:
🎯 Curative: Modern radiotherapy can cure many cancers while preserving vital organs and function.
📉 Effective: Advanced techniques stop disease progression, shrink tumours, and effectively manage spread.
👤 Patient-centred: We see the individual behind the diagnosis, supporting quality of life.
Every cancer journey is unique, but we are united in our mission to provide precise, efficient, and compassionate care for all. 🤝
👉 https://www.estro.org/
American Society for Radiation Oncology

UICC - Union for International Cancer Control World Cancer Day

12/12/2025

Optimal radiation planning drives optimal patient outcomes.

25/11/2025

Such a proud moment to be part of last night’s webinar on Building Leadership Capacity Across Global Oncology, and to sit on a panel alongside my mentor, Dr. Meredith Giuliani, as well as global leaders from TATA Memorial in India, AC Camargo in Brazil, and UHN in Toronto Canada.

This conversation is deeply relevant as we move toward 2030, where the global cancer burden is expected to rise dramatically. According to the International Agency for Research on Cancer, cancer incidence worldwide is projected to reach ~30 million new cases by 2040 — a ~60% increase from 2020. Much of this surge will already be evident by 2030.

‼️Even more crucial: about 70% of all cancer cases will occur in low- to middle-income countries, including the Philippines, where disparities in access, workforce, and resources remain significant.‼️

Sessions like this remind me that leadership in oncology is not just about expertise — it’s about collaboration, system-building, and creating pathways so patients everywhere receive safe, equitable, and compassionate cancer care.

Proud to represent the Philippines in this global dialogue. 🇵🇭